Profitable companies and non-Profitable Biotech companies (rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and Market Cap match the large global pharma. Dividend and consolidation could be the future drivers and continue to attract long term investors. Optimism prevails around the future of this sector as a whole which was reflected in the unprecedented rally in shares in 2012.
This trend continued in the next five years driven by launch of Innovative drugs catering to unmet needs in Alzheimer’s, HCV, osteoporosis, RA, Psoriasis, MS, Dyslipidemia, Cystic fibrosis, Cancer and orphan diseases. Drug approvals and label expansion of existing portfolio of launched drugs and data from late stage pipeline drugs should maintain the growth momentum and investors interest.
The early part of the previous decade (2010-20) was spent recovering from the big acquisitions made by this sector but followed by the exercising of some restrain for similar large acquisitions as investors wanted to see the returns reflected in the top-line and EPS. However in- licensing of early or mid stage compounds or small acquisitions continued since the Rising Stars kept throwing the bait by taking risks and innovate using novel technology platforms or validating novel targets for treating diseases.
Patent expiry impact was also modest as majority had “not so easy to copy” biologics and other drugs in their portfolio. They, however were not complacent and were not leaving any stones unturned to meet the challenges as well as exploring emerging market opportunities with local partners. Favorable regulatory environment finally saw biosimilar mAbs entry in regulated markets The optimism of biosimilar players is reflected in the maturing pipeline. Para IV Filing from other generic players continues to pour leaving room for surprises and volatility.
Moving forward the sector should see a strategic rise of the digital mindset and further adoption of transformative and augumentative technologies. While mergers & acquisitions can still expect a sharper focus despite being more traditional, external innovation should result in a meaningful shift in culture through innovative and creative partnerships with both new entrants and less traditional companies.
There will be an increasing demand for even more transparency and disclosure and a need for real relationship-driven partnerships will encroach across all sector stakeholders including regulators, patients, advocacy groups and also to outsourcing players critical to the supply chain. Data will be a dominating force behind new revenue models and crucial to understanding and delivering an exceptional patient experience. Pricing will continue to exert much pressure, increasing access to drugs, growth of gene and cell therapies, and uncertain trade policies will further change the dynamics of the market.
Industry News
- How Neuroblastoma Balances Replication Stress and Genome Stability Across Chromosome 17qby Bioengineer on August 9, 2026 at 9:37 am
Neuroblastoma, a cancer of the developing nervous system, has long challenged researchers because its behavior can vary dramatically from one patient to another. Some tumors respond well to treatment, while others grow aggressively, spread rapidly, and return despite intensive therapy. A new study published in the British Journal of Cancer examines one of the most
- Cigar, Cigarillo, and Pipe Smoking: Lung Cancer Risk and Screening Eligibilityby Bioengineer on August 9, 2026 at 4:37 am
A new study published in the British Journal of Cancer is challenging the way lung-cancer risk is discussed among people who do not smoke conventional cigarettes. Researchers led by S. Vaja, J.L. Dickson and C. Horst examined the effects of cigar, cigarillo and pipe smoking, focusing on two questions with immediate public-health consequences: how these
- How Low Gravity and Pressure Affect Space Manufacturing of Carbon-Fiber Structuresby Bioengineer on August 9, 2026 at 4:08 am
A new study is challenging one of the most persistent assumptions in space manufacturing: that building advanced composite structures beyond Earth is simply a matter of moving terrestrial production methods into orbit. Research published in npj Advanced Manufacturing examines how two defining features of the space environment—reduced gravity and reduced atmospheric pressure—can alter the manufacture
- Calreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectivenessby Bioengineer on August 9, 2026 at 3:54 am
Cancer researchers have reported a new strategy that combines bacterial tumor targeting, nutrient deprivation and immune stimulation in a single therapeutic design. The approach uses an engineered conjugate built from L-asparaginase and flagellin, linked to a system that directs the treatment toward calreticulin-bearing cancer cells. In experiments involving Salmonella-mediated tumor therapy, the conjugate enhanced antitumor
- Porous Reaction-Bonded Silicon Nitride: Size Effects in Pressureless Nitriding of Binder-Jetted Siliconby Bioengineer on August 9, 2026 at 2:59 am
A quiet shift in silicon manufacturing could be taking shape inside a new study on porous reaction-bonded silicon nitride, a ceramic material valued for its strength, thermal stability and resistance to chemical attack. Researchers T.G. Aguirre, E. Cakmak, M.D. Richardson and colleagues are investigating how the size of additively manufactured silicon components affects their conversion
- Short-Term Animal-Product Restriction Rapidly Alters Human Proteogenomic Profilesby Bioengineer on August 8, 2026 at 11:50 pm
A short-term decision to eat fewer or no animal products may begin reshaping the human body at the molecular level far sooner than many people expect, according to a new study published in Nature Communications. Research by A. Simistiras, O. Bocher, C. Emmanouil and colleagues examined how restricting animal-derived foods affects both gene activity and
- UVA-Induced Hyperploidization Causes Fibrosis in Post-Mitotic Fuchs Dystrophy Corneal Cellsby Bioengineer on August 8, 2026 at 11:44 pm
Fuchs endothelial corneal dystrophy, a progressive disorder that can gradually cloud the cornea and impair vision, may be driven by a cellular process more complex than simple cell loss. A new study published in Cell Death Discovery reports that ultraviolet-A light can induce chronic hyperploidization in corneal endothelial cells, triggering changes associated with fibrosis. The
- Study Explores PDLIM2 as Prognostic Biomarker and Treatment Target in Lung Adenocarcinomaby Bioengineer on August 8, 2026 at 11:27 pm
Lung adenocarcinoma is one of the most common forms of lung cancer and remains a major cause of cancer-related death worldwide. Although advances in imaging, molecular testing and targeted treatment have transformed care for some patients, the disease can behave very differently from one person to another. A new study published in the British Journal
- Healthy Vaccinee Effect Shapes Evaluation of Updated COVID-19 Vaccines in Older Adultsby Bioengineer on August 8, 2026 at 10:37 pm
The apparent benefits of updated COVID-19 vaccines in older adults may be influenced by more than the vaccines themselves, according to a study examining the “healthy vaccinee effect,” a form of bias that can complicate observational research. Published in Nature Communications, the work by Lyth, Spreco, Hinkula and colleagues focuses on how differences between people
- Nanoparticle pan-Ebolavirus vaccine protects rodents against lethal Zaire and Sudan virus infectionsby Bioengineer on August 8, 2026 at 9:19 pm
Ebola vaccine research has taken a step toward broader protection against one of the most persistent challenges in filovirus medicine: the existence of multiple Ebola virus species that can cause severe human disease. In a study published in Nature Communications, Weidle, Brunette, Wrenn and colleagues report that a pan-Ebolavirus nanoparticle vaccine protected rodents from lethal
- AI Framework Unifies MRI Tumor Segmentation, Grading, Staging, and Malignancy Detectionby Bioengineer on August 8, 2026 at 8:13 pm
Magnetic resonance imaging has long offered clinicians an extraordinarily detailed view of the human body, but turning those images into a complete and reliable cancer assessment remains a demanding task. A new study published in Nature Communications introduces MRICombo, a deep-learning framework designed to bring several major MRI analysis functions together: volumetric segmentation, disease grading,
- Peripheral Myh11-Expressing Nucleus Pulposus Cells Show Promise Against Disc Degenerationby Bioengineer on August 8, 2026 at 7:12 pm
A newly reported nucleus pulposus cell population could reshape how scientists understand the spine’s natural capacity for repair. In a study published in Nature Communications, Zhang, Chen, Shi and colleagues describe a previously unrecognized group of cells expressing Myh11, a gene traditionally associated with contractile smooth-muscle cells and vascular tissues. The discovery places these Myh11-expressing
- Pulmonary Hypertension and Acute Hypoxic Respiratory Failure in Premature Infantsby Bioengineer on August 8, 2026 at 6:24 pm
Pulmonary hypertension in preterm infants is emerging as one of the most difficult cardiovascular and respiratory problems in neonatal medicine, according to a new narrative review published in the Journal of Perinatology. The condition can intensify hypoxic respiratory failure, contribute to bronchopulmonary dysplasia and substantially increase the risk of death. Yet the authors emphasize that
- Stochastic Thermodynamics Reveals Social Imitation Beyond Energy Costsby Bioengineer on August 8, 2026 at 5:29 pm
Social imitation is often described with the language of energy. One person adopts an opinion because it appears socially advantageous, a behavior spreads because it is reinforced by its surroundings, or a group settles into a shared convention as though it were relaxing toward a preferred state. A new study by Irisarri, Trigal, Toral and
- Breastfed Infants’ Bacterial and Metabolic Profiles Shift During Transition to Solid Foodsby Bioengineer on August 8, 2026 at 5:23 pm
The first spoonful of solid food marks more than a milestone in an infant’s daily routine. It also begins a major biological transition in the gut, where a microbial community shaped largely by breast milk must adapt to a new supply of carbohydrates, proteins, fats and plant-derived compounds. A study by Eva Pivrncova, Jan Bohm,
- Multi-population GWAS maps bladder cancer loci and smoking-related genetic riskby Bioengineer on August 8, 2026 at 2:46 pm
Bladder cancer is providing scientists with a sharper view of how inherited DNA and smoking-related biology combine to influence cancer risk. In a study published in Nature Communications, researchers led by L. Prokunina-Olsson, O. Florez-Vargas and M.G. Levin conducted a multi-population genome-wide association study, or GWAS, meta-analysis to identify genetic regions associated with susceptibility to
- Scientists map signaling networks driving disseminated glioblastoma cells in living brainsby Bioengineer on August 8, 2026 at 1:50 pm
Glioblastoma has long been regarded as one of the most difficult cancers to understand and treat, not only because of its rapid growth but also because its cells can escape the primary tumor and establish themselves in distant regions of the brain. A study by Ahn, D’Souza, Long and colleagues, published in Nature Communications in
- Engineered nanovesicles targeting m6A writer METTL3 curb neuroinflammation in cells and animalsby Bioengineer on August 8, 2026 at 12:48 pm
Neuroinflammation, the persistent activation of the brain’s immune system, is increasingly recognized as a common driver of neurological damage. It appears in conditions ranging from neurodegenerative diseases to traumatic injury and viral infections of the central nervous system. A study by Xu, Pan, Li and colleagues, published in Nature Communications, reports that engineered nanovesicles designed
- Hebrew University Congratulates Haim Sompolinsky on Receiving 2026 Dirac Medalby Bioengineer on August 8, 2026 at 12:29 pm
Theoretical physicist and neuroscientist Haim Sompolinsky has been awarded the 2026 Dirac Medal and Prize, one of the most prestigious international honors in theoretical physics. The award, presented by the Abdus Salam International Centre for Theoretical Physics (ICTP), recognizes Sompolinsky alongside Deepak Dhar of the Indian Institute of Science Education and Research Pune, Bernard Derrida
- ESM1-Mediated DNMT3A Suppresses Cervical Cancer Metastasis via ID3 Epigenetic Regulationby Bioengineer on August 8, 2026 at 10:22 am
Cervical cancer metastasis may be controlled by an epigenetic pathway involving the endothelial cell-specific molecule 1, the DNA-methylating enzyme DNMT3A, and the transcription factor ID3, according to a study published in Cell Death Discovery. The research by Yu, Lin, Lee and colleagues describes how ESM1-mediated regulation of DNMT3A suppresses the spread of cervical cancer by
- Protecting Your Drug Patent in Global Markets: Strategies and Challengesby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 27, 2025 at 9:19 am
Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source
- Drafting Drug Patent Applications for Biologic Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 26, 2025 at 11:45 am
The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source
- Successfully Patenting Drug Combinations: Strategies and Challengesby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 26, 2025 at 9:57 am
Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source
- Effective Strategies for Generic Drug Price Settingby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 25, 2025 at 9:17 am
The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source
- Optimizing the Generic Drug Supply Chain: Strategies for Successby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 24, 2025 at 11:56 pm
Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source
- FDA Updates: What Do the Latest Changes Mean for Generic Drug Approval?by Insights: DrugPatentWatch - Find Your Next Blockbuster on February 24, 2025 at 8:55 pm
Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source
- Regulatory Challenges in the Latin American Generic Drug Marketby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 24, 2025 at 4:10 pm
Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source
- Analyzing the cost-effectiveness of biosimilars in different healthcare systemsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 23, 2025 at 11:27 am
The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source
- How to Achieve High-Quality Standards in Generic Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 20, 2025 at 11:21 am
Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source
- The Role of Quality Assurance in Generic Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 19, 2025 at 11:07 am
The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source
- DrugChatter: Can lurbinectedin treat ovarian cancer?by DrugChatter on February 19, 2025 at 6:44 am
Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source
- Regulatory considerations for biosimilar clinical efficacy trialsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 18, 2025 at 3:27 pm
Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source
- The basics of drug patent searchingby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 18, 2025 at 10:38 am
Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source
- Navigating the Generic Drug Approval Process: A Comprehensive Guideby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 17, 2025 at 10:33 am
Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source
- Strategies for successful biosimilar-to-biosimilar switchingby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 16, 2025 at 4:04 pm
The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source
- Study Reveals Key Predictors of Early Patent Challenges for FDA-Approved Drugsby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 14, 2025 at 11:40 am
The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source
- The Role of Partnerships in Generic Drug Developmentby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 13, 2025 at 9:12 am
Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source
- DrugChatter: Does fish oil interact with vascepa?by DrugChatter on February 12, 2025 at 9:10 pm
Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source
- How to Manage Generic Drug Development Timelines: Strategies for Successby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 12, 2025 at 9:10 am
The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source
- DrugChatter: How does lipitor affect white wine?by DrugChatter on February 11, 2025 at 4:56 pm
The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source
